CAS: 1346704-33-3 - GSK 343
Formule :C31H39N7O2
InChI :InChI=1S/C31H39N7O2/c1-6-7-23-14-21(4)35-31(40)26(23)18-33-30(39)25-15-24(16-28-27(25)19-34-38(28)20(2)3)22-8-9-32-29(17-22)37-12-10-36(5)11-13-37/h8-9,14-17,19-20H,6-7,10-13,18H2,1-5H3,(H,33,39)(H,35,40)
Code InChI :InChIKey=ULNXAWLQFZMIHX-UHFFFAOYSA-N
SMILES :O=C(NCC=1C(=O)NC(=CC1CCC)C)C2=CC(=CC3=C2C=NN3C(C)C)C=4C=CN=C(C4)N5CCN(C)CC5
- Synonymes :
- 1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide
- 1H-Indazole-4-carboxamide, N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-
- Gsk 343
- N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide
Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
---|---|---|---|---|
GSK 343 REF : IN-DA009CC5CAS : 1346704-33-3 | 98% | À demander | lun 25 Nov 24 | |
GSK343 REF : TM-T6059CAS : 1346704-33-3 | 98% - 99.9% | 58,00 €~500,00 € | lun 02 Déc 24 | |
GSK343 REF : 3D-WDC70433CAS : 1346704-33-3 | Min. 95% | À demander | mar 07 Jan 25 |
GSK 343
Ref: IN-DA009CC5
1mg | 103,00 € | ||
5mg | 106,00 € | ||
10mg | 196,00 € | ||
25mg | 341,00 € | ||
50mg | 573,00 € | ||
100mg | À demander |
GSK343
Ref: TM-T6059
5mg | 58,00 € | ||
10mg | 94,00 € | ||
25mg | 168,00 € | ||
50mg | 276,00 € | ||
100mg | 500,00 € | ||
1mL*10mM (DMSO) | 71,00 € |
GSK343
Ref: 3D-WDC70433
5mg | À demander | ||
10mg | À demander | ||
25mg | À demander | ||
50mg | À demander | ||
100mg | À demander |